The clinical characteristics of COVID-19: a retrospective analysis of 104 patients from the outbreak on board the Diamond Princess cruise ship in Japan

Background: The ongoing outbreak of the coronavirus disease 2019 (COVID-19) is a global threat. Identification of markers for symptom onset and disease progression is a pressing issue. We compared the clinical features on admission among patients who were diagnosed with asymptomatic, mild, and severe COVID-19 at the end of observation. Methods: This retrospective, single-center study included 104 patients with laboratory-confirmed COVID-19 from the mass infection on the Diamond Princess cruise ship from February 11 to February 25, 2020. Clinical records, laboratory data, and radiological findings were analyzed. Clinical outcomes were followed up until February 26, 2020. Clinical features on admission were compared among those with different disease severity at the end of observation. Univariate analysis identified factors associated with symptom onset and disease progression. Findings: The median age was 68 years, and 54 patients were male. Briefly, 43, 41, and 20 patients on admission and 33, 43, and 28 patients at the end of observation had asymptomatic, mild, and severe COVID-19, respectively. Serum lactate hydrogenase levels were significantly higher in 10 patients who were asymptomatic on admission but developed symptomatic COVID-19 compared with 33 patients who remained asymptomatic throughout the observation period. Older age, consolidation on chest computed tomography, and lymphopenia on admission were more frequent in patients with severe COVID-19 than those with mild COVID-19 at the end of observation. Interpretation: Lactate dehydrogenase level is a potential predictor of symptom onset in COVID-19. Older age, consolidation on chest CT images, and lymphopenia might be risk factors for disease progression of COVID-19 and contribute to the clinical management. Funding: Not applicable.


Role of the funding source
There was no funding source for this study. The corresponding author had full access to all 1 4 5 study-related data and had final responsibility for the decision to submit the study for publication. laboratory-confirmed COVID-19 were hospitalized in the Self-Defense Forces Central Hospital in 1 5 0 Japan. Three patients were excluded from the study because of withdrawal of consent to join the 1 5 1 study. Therefore, the remaining 104 patients were included in the final analysis. The patients' clinical 1 5 2 history, physical examination, and chest CT findings were evaluated on the day of admission, and all 1 5 3 blood tests were completed within the first 2 days following admission. The characteristics of 104 Eastern Asia, with Japanese and Chinese ethnicities as the majority. The range of observation period was 3-15 days (median, 10 days; IQR, 7-10 days). Fifty-two (50·0%) patients had comorbidities. Based on their presentation on the day of admission, 43 patients (41·4%) who did not display any symptoms were classified as asymptomatic, whereas 41 (39·4%) and 20 (19·2%) patients were 1 6 0 classified to have mild and severe COVID-19, respectively. . CC-BY 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
is the (which was not peer-reviewed) The copyright holder for this preprint . https: //doi.org/10.1101//doi.org/10. /2020 The clinical findings of the patients who were symptomatic on the day of admission and at the end of reports of complications or death during the observation period. The characteristics of 10 patients who developed symptomatic COVID-19 during the observation period among those who were asymptomatic on admission are presented in Table 3. Among these 10 significantly higher in patients who were initially asymptomatic but developed symptomatic of comorbidities are considered as potential risk factors for disease progression and poor prognosis. consequently leading to secondary bacterial infections. 14 In the present study, we observed In the present study, the prevalence of consolidation detected by chest CT was significantly higher in 2 5 6 severe cases than in mild cases. Consolidation was also frequently detected in patients who course of COVID-19 and that the appearance of consolidation was more frequent within 1-3 weeks consolidation on CT is associated with disease deterioration. Generally, consolidation is easily 2 6 3 detectable by chest X-ray, which therefore might be useful for the evaluation of risk for disease 2 6 4 progression in patients with COVID-19 in settings with limited resources. Additionally, CT imaging revealed a high prevalence of lung abnormalities in patients with  . CC-BY 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
is the (which was not peer-reviewed) The copyright holder for this preprint . https: //doi.org/10.1101//doi.org/10. /2020  show multifocal GGO adjacent to the parietal pleura in multiple lobes with emphysematous changes. GGO with crazy-paving appearance.

2 5
. CC-BY 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10. 1101/2020  . CC-BY 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
is the (which was not peer-reviewed) The copyright holder for this preprint . https: //doi.org/10.1101//doi.org/10. /2020  NSAID, non-steroidal anti-inflammatory drug; SpO 2 , peripheral capillary oxygen saturation 4 3 1 . CC-BY 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10. 1101/2020  . CC-BY 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10. 1101/2020